In line with our philosophy of enriching human lives through applied innovation, we, at Pulse, have made substantial investments in creating a world-class infrastructure.
Our Manufacturing facility in Roorkee, Uttarakhand and R&D facility in Hyderabad, are equipped with the finest machinery and state-of-the-art technology, and are operated by some of the most brilliant minds in the Pharmaceutical industry.
Pulse has always been a pioneer in embracing new technologies and upgrading its facilities to meet the demands of an ever-changing market. Consistent investment in technology and infrastructure, we believe, will provide us a competitive advantage, while also determining our future growth and expansion.
Our Manufacturing facility in Roorkee, Uttarakhand and our loan-licensed (outsourced) facility in Hyderabad, are strictly in line with Global Regulatory Standards. We are in the process of setting up two more facilities to manufacture novel/differentiated generic products, as well as speciality-rich generic products in various oral and topical dosage forms.
All our Technical Operations are overseen and managed by seasoned professionals with years of experience in Plant Operations in the highly regulated Pharmaceutical manufacturing sector.
Our facilities manufacture products for both: in-house consumption (Domestic & Exports), as well as for other major Indian Pharmaceutical companies/MNCs. Our Quality Assurance measures meet the best in the industry practice, to ensure that every batch that comes out of our Manufacturing units, is of the finest quality and meets Global Standards.
Research & Development
Pulse Advanced Research Center or PARC, set up in Hyderabad in 2010, is a strong R&D infrastructure that forms the backbone to Pulse consistently delivering innovative products. The world-class infrastructure, high-quality manpower and pathbreaking innovations by PARC, are indeed a matter of immense pride for us.
Our Novel Pharmaceutical Formulation Research & Development wing, wherein we develop Cutting-edge Proprietary Technologies using advanced pharmaceutical and material sciences like Nanotechnology – these are further developed into highly differentiated Pharmaceutical Formulation products. This facility is housed with the most sophisticated equipment to handle great levels of Characterisation of material and products.
Our Analytical Research & Development laboratory is well-equipped with machinery and men to handle Complex Analytical Method Development and Validations.
Our Formulation Research & Development team is engaged in developing difficult-to-handle Niche and Generic Formulations.
Our State-of-the-art Formulation R&D facility is equipped to carry out various product development activities such as API Characterization, Pre-Formulation Studies, Excipient Compatibility Studies, Composition & Process Optimization, Stability Studies etc., in line with ICH and WHO guidelines. Scale-Up, Process Validation, and Manufacture of Registration/ Submission Batches for various dosage forms are also carried out as per the regulatory norms.
Our Process Research & Development laboratory focuses on developing innovative, cost-effective process technologies for select active pharmaceutical ingredients, in line with the business strategy of the company.
Equipped with State-of-the-art infrastructure and adhering to the strictest Global Standards of GLP (Good Laboratory Practice), our PR&D laboratory can handle both - typical Organic Chemical Reactions such as Chiral Synthesis, Chiral Resolutions, Isomerization, Saponification, Reductions & Oxidations, Asymmetric Synthesis, Enzyme Catalyzed Reactions, Peptide Synthesis and Industrial Chiral Chromatography, as well as Industrial Chemicals/Gases such as Triphosgene, Raney Nickel, Sodium Borohydride, Palladium Catalyst, Sodium metal, Hydrogen and Isobutylene.
Sales & Marketing
With a pan-India presence and a field force of over 500, Pulse reaches out to more than 40, 000 Health Care Professionals across the country. This, in addition to our Overseas Operations, that have seen us spread to South East Asia, Russia & CIS and Africa.
We have divided our Sales & Marketing Operations into three categories – Nucleus, Stimulus and International Marketing.
Under this division, over 250 TBEs cover around 30, 000 Doctors across Orthopaedics, Gynaecology and General Physician specialities. Xtracal, promoted by this division, commands a significant share in the Calcium preparations market.
Around 80 TBEs cover over 10, 000 Doctors across the specialities of Neurology, Orthopaedics, Cardiology, Diabetology, ENT and Family Physician, under this division. Doloneuron and its extensions, promoted by this division, are well-established with Physicians for the treatment of neuropathic pain.
As part of our International expansion, we have inked several distribution agreements with leading Pharmaceutical importers in the ASEAN and African regions. A phase-wise expansion plan is in place to cover the LATAM and CIS regions too. We provide products and the necessary marketing support to our International Importers, so that they can sell our products through their Sales & Distribution channels in their respective countries.
Our Distribution Network is a well-oiled machinery aimed at ensuring the highest level of service to our customers in the shortest time frame.
We have 13 C&F Agents strategically located across the country, who in turn, supply our products to over 460 Authorized Dealers/Stockists. The collective reach of our Distribution Network has crossed over 150, 000 Retail Pharmacies, Hospital Pharmacies and consulting Doctors.